Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 4Pain, Postoperative 3Spondylitis, Ankylosing 2Pain 2Neoplasms 2Lung Neoplasms 2Colonic Neoplasms 2Agnosia 2Uterine Cervical Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Sexual Dysfunction, Physiological 1Pituitary Neoplasms 1Ovarian Neoplasms 1Neoplasm, Residual 1Mucositis 1Lymphoma, Follicular 1Inflammation 1Head and Neck Neoplasms 1Endometrial Neoplasms 1Chronic Pain 1Carcinoma, Non-Small-Cell Lung 1Arthritis, Rheumatoid 1Arthritis, Psoriatic 1Anastomotic Leak 1Adenocarcinoma of Lung 1Acute Pain 1

Interventions

Adalimumab 19Etanercept 16Methotrexate 11Infliximab 8tocilizumab 7Rituximab 7golimumab 6Abatacept 6tofacitinib 5Tumor Necrosis Factor Inhibitors 5olokizumab 4Certolizumab Pegol 4Antirheumatic Agents 3Saline Solution 2RC-18 2Nivolumab 2Leflunomide 2veltuzumab 1upadacitinib 1secukinumab 1sarilumab 1mavrilimumab 1entecavir 1cabozantinib 1baricitinib 1andecaliximab 1Vitamin D 1Vaccines 1TACI receptor-IgG Fc fragment fusion protein 1Syringes 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Arthritis, Rheumatoid × Anti-Inflammatory Agents, Non-Steroidal × Clear all
NCT02878161 2016-08-25

Predictability Studies on the Efficacy of TNF-α Inhibitors in Chinese RA From "Real World"

Central South University

Phase 4 Unknown
240 enrolled

Arthritis, Rheumatoid

Data powered by HemOnc (CC BY 4.0) Colophon âš¡